Viewing Study NCT05251766


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-01-26 @ 4:57 AM
Study NCT ID: NCT05251766
Status: UNKNOWN
Last Update Posted: 2022-02-23
First Post: 2022-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
Sponsor: Xuli Meng
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Chemotherapy Effect View
Keywords: